scholarly journals Relationship between Programmed Cell Death Protein Ligand 1 Expression and Immune-related Adverse Events in Non-small-cell Lung Cancer Patients Treated with Pembrolizumab

JMA Journal ◽  
2019 ◽  
Oncotarget ◽  
2017 ◽  
Vol 8 (37) ◽  
pp. 61618-61625 ◽  
Author(s):  
Hidenobu Ishii ◽  
Koichi Azuma ◽  
Akihiko Kawahara ◽  
Norikazu Matsuo ◽  
Takaaki Tokito ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document